LTR Pharma (ASX:LTP) Interest Expense : A$ Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. LTR Pharma's interest expense for the six months ended in Jun. 2023 was A$ 0.00 Mil. LTR Pharma does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Jun. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. LTR Pharma's Operating Income for the six months ended in Jun. 2023 was A$ -1.44 Mil. LTR Pharma's Interest Expense for the six months ended in Jun. 2023 was A$ 0.00 Mil. LTR Pharma has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

LTR Pharma Interest Expense Historical Data

The historical data trend for LTR Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Interest Expense Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Interest Expense

-0.01

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Interest Expense	-0.01	-	-

LTR Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

LTR Pharma (ASX:LTP) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LTR Pharma's Interest Expense for the six months ended in Jun. 2023 was A$0.00 Mil. Its Operating Income for the six months ended in Jun. 2023 was A$-1.44 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

LTR Pharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

LTR Pharma Ltd has no debt.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines